Next Article 
Journal of Virology, December 1999, p. 9695-9701, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Effect of Cytoplasmic Tail Truncations on the
Activity of the M2 Ion Channel of Influenza A
Virus
Kurt
Tobler,1
Marie L.
Kelly,2
Lawrence H.
Pinto,2 and
Robert A.
Lamb1,3,*
Department of Biochemistry, Molecular
Biology, and Cell Biology,1 Department
of Neurobiology and Physiology,2 and
Howard Hughes Medical Institute,3
Northwestern University, Evanston, Illinois 60208-3500
Received 30 June 1999/Accepted 20 August 1999
 |
ABSTRACT |
The M2 protein of influenza A virus forms a proton
channel that is required for viral replication. The M2 ion
channel is a homotetramer and has a 24-residue N-terminal extracellular
domain, a 19-residue transmembrane domain, and a 54-residue cytoplasmic tail. We show here that the N-terminal methionine residue is cleaved from the mature protein. Translational stop codons were introduced into
the M2 cDNA at residues 46, 52, 62, 72, 77, 82, 87, and 92. The deletion mutants were designated truncx, according to
the amino acid position that was changed to a stop codon. We studied the role of the cytoplasmic tail by measuring the ion channel activity
(the current sensitive to the M2-specific inhibitor
amantadine) of the cytoplasmic tail truncation mutants expressed in
oocytes of Xenopus laevis. When their conductance was
measured over time, mutants trunc72, trunc77, and trunc92 behaved
comparably to wild-type M2 protein (a decrease of only 4%
over 30 min). In contrast, conductance decreased by 28% for trunc82,
27% for trunc62, and 81% for trunc52 channels. Complete closure of
the channel could be observed in some cells for trunc62 and trunc52
within 30 min. These data suggest that a role of the cytoplasmic tail
region of the M2 ion channel is to stabilize the pore
against premature closure while the ectodomain is exposed to low pH.
 |
INTRODUCTION |
The M2 integral membrane
protein of influenza A virus is a minor but essential component of
virions (48). However, it is abundantly expressed at the
cell surface of virus-infected cells (27). The
M2 mRNA encodes a polypeptide of 97 amino acids
(26), and the protein forms a homotetramer either consisting
of a pair of disulfide-linked dimers or completely disulfide linked as
a tetramer (16, 29, 40). The protein is orientated in
membranes such that it has 24 N-terminal extracellular (or lumenal)
residues, a 19-residue transmembrane (TM) domain, and a 54 residue
cytoplasmic tail (27, 48).
The M2 protein has an ion channel activity that functions
during uncoating of virions in endosomes, permitting protons to enter
the virion and bringing about dissociation of protein-protein interactions, principally weakening those between the matrix
(M1) and nucleocapsid protein (for reviews, see references
14 and 25). In addition, the
M2 protein functions during its transport through the
exocytic pathway. There the M2 protein ion channel activity
causes equilibration of pH of the lumen of the trans Golgi
network with the cytoplasm (4, 13, 33). Evidence that the
M2 protein has ion channel activity has been obtained by
expressing the M2 protein in oocytes of Xenopus
laevis or in mammalian cells and measuring cell surface currents
(3, 17, 18, 32, 37, 43-45). The M2 protein ion
channel activity is specifically blocked by the anti-influenza virus
drug amantadine, and the M2 ion channel is activated at the
lowered pH found intralumenally in endosomes and the trans
Golgi network (3, 32, 37, 45). Measurement of the ion
channel activity of mixed oligomers of M2 containing both
amantadine-sensitive and amantadine-resistant subunits indicated that
the active oligomeric form of the M2 ion channel is the
homotetramer (34). In addition to the in vivo measurements,
the M2 protein ion channel activity has also been shown by
reconstitution of purified M2 protein into planar lipid bilayers and by incorporation of a synthetic peptide corresponding to
the TM domain into planar bilayers. In both cases, amantadine-sensitive currents were measured (5, 36, 41).
As the M2 protein contains only a single hydrophobic
domain, the four TM domains must encompass the pore region of the ion channel. If the TM domain is modeled as an
-helical bundle, then mutations in the M2 TM domain which confer amantadine
resistance (predominantly residues 27, 30, 31, and 34) map to one face
of the presumptive
-helix (14, 15, 40). Furthermore,
histidine 37, which is believed to be directly involved in proton
conduction (31, 43), maps to the same face of the
-helix.
The inhibition of the M2 ion channel activity by
Cu2+ is also consistent with histidine 37 facing the pore
(11). The model that M2 residues 27, 30, 34, and
37 (heptad repeat residues a and d) would face
the interior pore region of the four-helix bundle has been proposed.
Several lines of evidence support this model: (i) circular dichroism
studies of the TM domain peptide in membranes indicates it is
-helical in structure (7, 23); (ii) when a series of
mutants with successive cysteine substitutions in the TM domain were
expressed and properties of the altered M2 ion channels
(reversal potential, ion currents, and amantadine resistance) were
measured, Fourier analysis indicated a periodicity of 3.4 amino acid
residues per turn of the helix, consistent with that expected for a
four-stranded coiled coil or helical bundle (31); (iii) when
the ability of the TM domain cysteine substitution mutants to form
disulfide bonds under oxidizing conditions was measured, the most rapid
cross-linking was at residues 27, 30, 34, 37, and 41, positions which
correspond with the predicted interior of the pore (1); (iv)
molecular modeling and simulation studies predict a left-handed
four-helix bundle (9, 24, 31, 35, 49); and (v) solid-state
nuclear magnetic resonance data, using a synthetic peptide
corresponding to the TM domain region of M2, indicate that
the helices are packed together in a left-handed four-helix bundle with
a 33° tilt angle with respect to the membrane bilayer
(23).
Although it has been suggested that the M2 protein
ectodomain may be involved in incorporation of the M2
protein into virions (30) and that the M2
cytoplasmic tail may be important for interactions with other influenza
virus proteins, in particular the matrix (M1) protein
(2, 46), the role of these domains, if any, in the ion
channel activity has not been determined. Here we describe properties
of the M2 protein containing truncations to its cytoplasmic tail and show that the M2 protein cytoplasmic tail is
important for maintaining the ion channel activity.
 |
MATERIALS AND METHODS |
Construction of plasmids.
The M2 cDNA of
influenza A virus/Udorn/72 (48) was cloned into plasmid
pGEM3 such that M2-specific RNA could be transcribed using
the bacteriophage T7 promoter and T7 RNA polymerase. The USE (unique
site elimination) mutagenesis system (Pharmacia Biotech, Piscataway,
N.J.) was used to generate C-terminal truncation mutants of the
M2 protein. The nucleotide sequences of the mutants were confirmed by using an ABI Prism 310 genetic analyzer (Applied Biosystems Inc., Foster City, Calif.).
Cell culture and transient expression of proteins.
HeLa T4
cells were grown in Dulbecco's modified Eagle's medium containing
10% fetal calf serum. The M2 proteins were expressed in
HeLa T4 cells by using the vaccinia virus-T7 RNA polymerase (vac-T7)-mediated transient expression system as described previously (17). In brief, cells at 70 to 80% confluency were infected with recombinant vaccinia virus vTF7.3, which expresses the
bacteriophage T7 RNA polymerase gene. Fourty-five minutes
postinfection, cells were transfected with pGEM3 containing the cDNA
for the wild-type (wt) M2 protein or the C-terminal
deletion mutants.
Flow cytometry.
The M2 proteins were expressed
in HeLa T4 cells by using the vac-T7-mediated transient expression
system. Six hours posttransfection, cells were washed with ice-cold
phosphate-buffered saline (PBS) containing 0.02% sodium azide. All
further incubations were performed at 4°C. The monolayer was
incubated for 30 min with PBS supplemented with 0.02% sodium azide,
0.1% bovine serum albumin, and 2% fetal calf serum (PBS-A), incubated
for 1 h with M2-specific monoclonal antibody (MAb)
14C2 (47) at 1:1,000 dilution in PBS-A, washed four times
with PBS, incubated for 30 min with fluorescein-conjugated goat
anti-mouse immunoglobulin G diluted 1:1,000, and washed four times more
with PBS to remove unbound secondary antibody. To detach the cells from
the dish, cells were incubated with 0.5 ml of PBS containing 5 mM EDTA.
The cells were transferred to tubes containing 0.5 ml of PBS and
supplemented with 2% formaldehyde. Fluorescence intensity of 10,000 cells was measured by a FACScalibur flow cytometer (Becton Dickinson & Co., Mountain View, Calif.).
Immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE).
Proteins were radiolabeled with
[35S]methionine and/or [35S]cysteine (50 µCi/ml for 1 h at 5 h posttransfection. Cells were lysed, and M2 proteins were immunoprecipitated with MAb 14C2
(47). Polypeptides were analyzed on 17.5% acrylamide gels
containing 4 M urea (17). 14C-labeled molecular
weight standards (Amersham Life Sciences, Arlington Heights, Ill.) were
used. The gels were subjected to autoradiography.
In vitro transcription.
pGEM3 plasmid DNA encoding the
M2 proteins was linearized downstream of the
M2-encoding region with HindIII, and capped
RNA was transcribed in vitro by using an mMessage mMachine T7
transcription kit as instructed by the manufacturer (Ambion, Austin,
Tex.).
Microinjection and culture of oocytes.
Ovarian lobules from
X. laevis females were surgically removed and treated with
collagenase B (2 mg/ml; Boehringer Mannheim Biochemicals, Indianapolis,
Ind.). Defolliculated oocytes were injected via a 20-µm-diameter
glass pipette with mRNA transcribed in vitro, and the oocytes were
maintained in ND96 at 17°C (32).
Recording of ion channel activity.
Whole-cell current was
measured with a two-electrode voltage-clamp apparatus 2 to 3 days after
mRNA injection. The electrodes were filled with 3 M KCl, and the
oocytes were bathed in ND96. The traces were recorded with pCLAMP
(version 7.1; Axon Instruments, Foster City, Calif.). Whole-cell
currents were measured while gradually increasing the membrane
potential from
120 to +60 mV. The holding voltage was
20 mV. For
both wt and mutant channels, the current was first measured in Barth's
solution at pH 7.5. The pH of the medium was then decreased to pH 6.2;
after a 2-min incubation in solution of pH 6.2, the current was
remeasured. The conductance, measured as the slope of the
current-voltage relationship, was determined between
80 and
40 mV.
The amount of endogenous current and leakage current was determined by
measuring the current-voltage relationship while the cell was bathed in Barth's solution containing amantadine (pH 6.2). The current
attributable to the M2 ion channel was calculated by
subtracting the current measured in the presence of amantadine from the
current measured without amantadine (pH 6.2). We did not use the data
from cells in which significant endogenous currents or leakage currents
were observed.
 |
RESULTS |
Expression of M2 proteins containing cytoplasmic tail
deletions.
To test whether the cytoplasmic tail of the
M2 protein is involved in regulating its ion channel
activity, truncation mutants were constructed. Translational stop
codons were introduced into the M2 cDNA at amino acid
positions 46, 52, 62, 72, 77, 82, 87, and 92 (Fig.
1). The deletion mutants were designated
truncx, according to the amino acid position that
was changed to a stop codon.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Amino acid sequence of the influenza virus
M2 protein (strain A/Udorn/72) and the C-terminal
truncation mutants. The presumptive transmembrane domain residues are
shaded.
|
|
To determine whether the M2 protein expression was affected
by deletion of the cytoplasmic tail, the proteins were expressed in
HeLa T4 cells by using the vac-T7-mediated transient expression system.
The transfected cells were metabolically labeled with [35S]methionine or [35S]cysteine, and
M2 proteins were immunoprecipitated from cell lysates by
using MAb 14C2, which is specific to the N-terminal ectodomain, and
polypeptides were analyzed by SDS-PAGE. As shown in Fig.
2A, when the proteins were labeled with
[35S]cysteine, the mutant M2 proteins
exhibited a cascade of mobilities consistent with the extent of the
truncation. The M2 protein contains three cysteine residues
(17, 19, and 50), and trunc46 lacks cysteine residues 50. Thus, the
observation that M2 trunc46 accumulated less
[35S]cysteine-labeled polypeptide than the other
truncation mutants is consistent with the protein sequence. When the
M2 truncation mutants were labeled with
[35S]methionine, mutants trunc92, trunc87, trunc82, and
trunc77 were readily detected and the other truncation mutants were
essentially undetectable (Fig. 2B). The M2 protein sequence
predicts methionine residues at residue 1 (the initiation methionine
residue) and at residue 72. Therefore, the data shown in Fig. 2B are
consistent with cleavage of the initiation methionine residue from the
mature protein, and thus M2 protein contains 96 residues.
This experimental finding is consistent with the finding that for
cytosolic proteins, small, uncharged residues next to the initiation
codon (Ala, Gly, Pro, Ser, and Thr) promote N-terminal processing of
the initiation methionine residue (8).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of the M2 protein truncation
mutants from cDNAs. HeLa T4 cells were infected with vac-T7 and
transfected with plasmids encoding the wt M2 protein or the
truncation mutants. At 5 h posttransfection, the cells were
labeled with [35S]methionine (A),
[35S]cysteine (B), or [35S]cysteine (C).
The cells were lysed, proteins were immunoprecipitated with MAb 14C2,
and polypeptides were analyzed by SDS-PAGE on 17.5% acrylamide gels
containing 4 M urea. (A and B) Electrophoresis under reducing
conditions; (C) electrophoresis under nonreducing conditions. T,
tetramers; D, disulfide-linked dimers.
|
|
Disulfide bond formation of M2 proteins containing
cytoplasmic tail truncations.
As homotetramer formation is
believed to be obligatory for forming a functional M2 ion
channel, the ability of the deletion mutants to form disulfide-linked
dimers and tetramers was examined. The wt M2 protein and
the deletion mutants were expressed in HeLa T4 cells and radiolabeled
with [35S]cysteine. The M2 proteins were
immunoprecipitated from cell lysates, and proteins were analyzed by
SDS-PAGE under nonreducing conditions. As shown in Fig. 2C, all of the
truncation mutants formed a mixture of disulfide-linked dimers and
tetramers on SDS-PAGE, much like wt M2 protein, and thus
the data suggest that all of the truncation mutants formed
homotetrameric species that were either a dimer of disulfide-linked
dimers or a completely disulfide-linked tetramer.
Cell surface expression of M2 proteins containing
cytoplasmic tail truncations.
The wt M2 protein is
abundantly expressed on the surface of influenza virus-infected cells
(27). As the length of the C-terminal cytoplasmic tails
might influence the transport of the truncation mutants to the plasma
membrane, surface expression of the truncation mutants in mammalian
cells was quantified by flow cytometry. The wt M2 protein
and the truncation mutant proteins were expressed by using the
vac-T7-mediated transient expression system; at 6 h
posttransfection, cells were analyzed by flow cytometry using MAb 14C2.
The percentage of cells expressing M2 proteins and the mean
fluorescence intensity were similar for trunc92, trunc82, trunc77, and
trunc72, although for all of these mutants the number of cells
expressing M2 protein was less than for wt M2
protein (Table 1). For trunc62, both the
percentage of cells expressing M2 protein and the mean
fluorescent intensity were reduced, and this lower-level surface
expression was more pronounced for trunc52. M2 trunc46 was
not detected at the cell surface. We have not investigated further the
reason for the reduced surface expression of trunc62 and trunc52 or the
lack of surface expression of trunc46.
Ion channel activities of M2 truncation mutant
proteins.
We compared the ion channel activity of each of the
M2 truncation proteins with that of the wt M2
protein by expressing the proteins in oocytes of X. laevis
and recording the membrane currents with a two-electrode voltage clamp
apparatus (32). The wt M2 protein has very low
ion channel activity at neutral pH, but its activity increases after
the pH of the bathing medium is lowered and is rapidly eliminated by
application of amantadine (100 µM) to the bathing medium (32,
45). We quantified the ion channel activity of the M2
proteins by measuring the current induced by a range of applied
voltages (
120 to +60 mV). This was done first in high-pH medium and
then for each of seven time points over the 30-min interval in which
the oocytes were bathed in medium of low pH. The measure of ion channel
activity that we used was the slope of the relationship between current
and voltage, or the conductance (Fig. 3 and
4).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of the ion channel activity of M2
truncation mutants with that of the wt M2 protein ion
channel. The transmembrane voltage was varied from 120 to +60 mV
while membrane current was measured after incubation of the oocyte for
2 min in medium of pH 6.2. (A) Truncation mutants with ion channel
properties similar to those of wt M2 protein (trunc92,
trunc77, and trunc72); (B) truncation mutants with activity less than
that of wt M2 protein (trunc82, trunc62, and trunc52). The
interrupted lines show the currents of wt M2 protein in pH
6.2 medium. The inhibition of the wt ion channel activity by amantadine
is shown in the top traces. Each trace represents the average total
current of at least two cells.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of abilities of the wt M2 protein
and truncation mutant proteins to sustain currents. The ability to
sustain was evaluated by measuring the amantadine-sensitive
conductance. Conductances for the mutant proteins were normalized
individually (conductance ratio) and plotted against time during which
the oocytes were bathed in a medium of pH 6.2 ( 20 mV holding
voltage). (A) Mutants trunc92, trunc77, and trunc72 sustained currents
during the 30-min incubation in solution of pH 6.2. (B) Conductances of
mutants trunc82, trunc62, and trunc52 declined by more than 25% during
the incubation in pH 6.2 medium.
|
|
We measured the current-voltage relationship of oocytes expressing the
M
2 truncation mutant proteins and compared them to
oocytes
expressing the wt M
2 protein. Only cells exhibiting
currents
that could be eliminated by the application of amantadine and
that were able to be recorded for the full time of the experiment
are
reported. Three of the truncation mutant proteins (trunc92,
trunc77,
and trunc72) had ion channel activity similar to that
of the wt
M
2 protein: they had low conductance at neutral pH,
their
conductance increased when the pH of the bathing solution
was lowered,
and their conductance was decreased by amantadine
(Fig.
3A). In
contrast, the ion channel activity of oocytes expressing
the remaining
truncation mutant proteins (trunc82, trunc62, and
trunc52) was less
than that of oocytes expressing the wt M
2 protein
(Fig.
3B). Recordings of trunc87 were not performed. Despite the
lower ion
channel activity, the ion selectivity of these proteins
did not differ
greatly from that of the wt M
2 protein. However,
the
reversal potentials of lower conducting channels such as trunc62
and
trunc52 were shifted. This is because the lower conducting
channels
were more adversely affected by endogenous currents than
the higher
conducting channels (Fig.
3B). Nonetheless, when the
amantadine-sensitive current was determined, it was found that
the
lower conducting mutants had a reversal potential comparable
to that of
wt M
2 (data not shown). Thus, the truncation mutant
proteins exhibited ion channel activities that could be quantitatively
compared to that of the wt M
2 protein.
We compared the ability of each of the truncation mutant proteins with
that of the wt M
2 protein to sustain ion channel activity
while bathed in medium of low pH. The ion channel activity of
the wt
M
2 protein was constant for as long as 30 min, while the
oocyte was bathed medium of pH 6.2 (Fig.
4). Ion channel activity
was
also sustained in oocytes that expressed truncation mutant
proteins
trunc92, trunc77, and trunc72 (Fig.
4A). However, the
same truncation
mutant proteins associated with lower ion channel
activity (trunc82,
trunc62, and trunc52) also failed to maintain
sustained ion channel
activity when expressed in oocytes that
were bathed in a solution of pH
6.2 (Fig.
4B).
One of the truncation mutant proteins that was similar to wt
M
2 protein in most respects, trunc92, differed from wt
M
2 protein
in one physiological property. After injection
of mRNA encoding
the wt M
2 protein, it is usually
satisfactory to incubate the
oocytes in a medium of pH 7.5 while the
protein is being expressed.
At this pH, the ion channel activity is
minimal, and the proton
flux across the plasma membrane does not result
in oocyte death;
however, when bathed in medium of lower pH, oocytes
die rapidly
(
12,
25). We noticed that oocytes expressing the
trunc92 mutant
protein had a higher rate of cell death than oocytes
expressing
either the wt M
2 protein or the other truncation
mutant proteins
incubated in medium of pH 7.5. However, cell death of
oocytes
expressing the trunc92 mutant protein was decreased when these
oocytes were incubated in a medium of pH 8.5 starting from the
time of
injection of mRNA. This suggests that the trunc92 mutant
protein has
greater ion channel activity than the wt M
2 protein
at
neutral
pH.
 |
DISCUSSION |
Oocytes expressing three truncation mutant proteins, trunc82,
trunc62, and trunc52, had lower ion channel activity than oocytes expressing the wt M2 protein (Fig. 3B). In principle, this
lower ion channel activity can result from either reduced surface
expression of the protein or reduced activity of the ion channel
macromolecular complex. It is likely that reduced ion channel activity
of oocytes expressing the trunc62 and trunc52 mutant proteins is the
result of reduced protein surface expression (Table 1). However, it is
unlikely that reduced surface expression can explain the reduced ion
channel activity of oocytes expressing the trunc82 protein (Table 1).
Instead, the reduced ion channel activity probably results from an
alteration in the structure of the trunc82 mutant ion channel protein.
Truncation of the cytoplasmic N and C termini of several other ion
channels has been demonstrated to alter their activity. In most cases,
the result is an increase in the activity of the channel (22,
28). One possible basis for the increase in activity of these
other ion channels is the removal of a peptide that is capable of
blocking the channel pore and thus causing inactivation
(20). However, the decrease in activity of the trunc82
mutant protein must have a mechanism different from the increase in
activity seen for truncation mutations of other ion channels.
Oocytes expressing the three truncation mutant proteins trunc82,
trunc62, and trunc52 were also unable to sustain ion channel activity
while bathed in medium of low pH (Fig. 4). Two fundamental properties
of ion channels are activation and inactivation. Activation is the
increase in ion channel activity that occurs upon presentation of the
appropriate stimulus. In the case of the M2 protein, this stimulus is lowered pH. Inactivation is the decrease in activity that
occurs after prolonged application of the activating stimulus. Oocytes
expressing these three truncation mutant proteins displayed a decrease
in inward current during prolonged exposure to low-pH medium. However,
a decrease in inward current does not necessarily signal that
inactivation has occurred, especially in oocytes. The reason is that
normally silent endogenous currents can be up-regulated by expression
of exogenous proteins, among them variants of the M2
protein (37). Two lines of evidence indicate that the
decrease of inward current that we observed does reflect the process of
inactivation for these mutant proteins. The currents of the
M2 protein are up-regulated by low pH of the bathing medium and are sensitive to the inhibitor amantadine. Application of amantadine eliminated the currents of oocytes that expressed the truncation mutant proteins. The second argument against endogenous currents being responsible for the observed decrease in current is
based on the observation that the amplitude of endogenous currents varies widely from frog to frog (38). If endogenous currents were responsible for the measured decrease in inward current, then the
decrease should have varied from frog to frog. However, the variability
that we observed in the decrease in inward current was from cell to
cell from the same frog and not from frog to frog. A second potential
cause for a decrease in current while the oocyte was bathed in a medium
of low pH is acidification of the intracellular medium of the oocyte
(37). However, this is not a likely explanation, as the
decrease in current was not greater for oocytes expressing greater currents.
Posttranslational modifications are capable of modifying the function
of many proteins, including ion channel proteins. The cytoplasmic
domain of the M2 protein is modified in several ways. Cysteine residue 50 is palmitylated (39, 42), and serine
residue 64 is the major site for phosphorylation, but serine residues, 82, 89, and 93 are also minor phosphorylation sites (18).
However, site-altered forms of the protein in which all of these
modifications are ablated show ion channel activity that is
indistinguishable from that of the wt M2 protein
(18). Thus, it seems unlikely that the mechanism by which
the truncations alter ion channel activity is due to lack of a site for
a posttranslational modification.
What is responsible for the observed decrease in ion channel activity
that results from truncation of the C terminus of the M2
protein? It is unlikely that the alterations are a sole consequence of
the number of residues truncated from the C terminus of the protein. If
this were so, then oocytes expressing the trunc82 protein would have
conductances larger than those of oocytes expressing the trunc77
protein. A second possibility is that the C terminus of each
M2 monomer has a secondary structure that is essential for
the stability of the M2 ion channel protein and that
disruption of the secondary structure of the channel protein results in
a decrease in channel activity, perhaps by destabilizing the protein. However, if such a secondary structure exists, it cannot be one whose
stability is directly proportional to its length, or the decrease in
current would be proportional to the length of the truncated segment of
the C terminus. An example of truncation affecting the state of an ion
channel can be found in the amiloride-sensitive Na+
channel, the activity of which is decreased by truncation of the C
terminus. The result of this truncation is to increase the probability
of the channel to exist in a low-conductance state at the expense of a
high-conductance state (10). Although the conducting states
of the M2 ion channel protein are not yet known, it is
possible that this mechanism also serves to explain the present results.
Three truncation mutant channels (trunc82, trunc62, and trunc52) did
not sustain ion channel activity in low pH; i.e., they partially
inactivated. Alterations of C-type inactivation also occur as a result
of deletions in the cytoplasmic C-terminal domain of Shaker-type
K+ channels. C-type inactivation (21) has slow
onset and can be studied in the absence of the more rapid N-type
inactivation that results from occlusion of the channel pore by amino
acids in the N terminus of the channel protein. Small deletions of the
C terminus of the Kv1.1 channel result in a slower onset of
inactivation, while large deletions in the region result in a more
rapid onset of inactivation (19). The alteration that
results in slower inactivation was mapped to a region containing five
amino acids. Thus, it is possible that certain C-terminal truncations
of the M2 protein result in the initiation of a process
similar to C-terminal inactivation of Shaker-type K+
channels, although with a slower time course.
These results have important implications for the study of the
structure and function of the M2 protein. Functional
studies of the ion channel activity (5) and structural
studies using circular dichroism (7, 23), neutron
diffraction (6), and solid-state nuclear magnetic resonance
(23) using the isolated M2 transmembrane peptide
have been reported. Our findings indicate that truncation of C terminus
of the protein leads to modification of the function of the ion channel
activity which is not directly proportional to the length of the
truncated segment. This implies that measurements made on the isolated
transmembrane peptide may not precisely reflect the properties of the
intact M2 ion channel protein.
The M2 cytoplasmic tail may be multifunctional. In addition
to being important for sustaining ion channel activity, the cytoplasmic tail may be important for interactions with other viral proteins, in
particular the M1 protein. In a reverse genetics
experiment, it was found that deletion of 5 or 10 residues from the
M2 cytoplasmic tail abrogated the ability to rescue
influenza virus (2). However, the failure to rescue the
virus does not permit distinction between alteration of ion channel
activity or a loss of protein-protein interactions. However, influenza
virus variants that escaped the growth restriction of MAb 14C2
contained changes in the M2 cytoplasmic tail or in the
M1 protein, suggesting an interaction between the M2 cytoplasmic tail and the M1 protein
(46, 47).
 |
ACKNOWLEDGMENTS |
This research was supported by Public Health Service research
grants R37 AI-20201 (R.A.L.) and AI-31882 (L.H.P.) from the National
Institute of Allergy and Infectious Diseases. K.T. was the recipient of
a fellowship from the Swiss National Science Foundation. R.A.L. is an
Investigator of the Howard Hughes Medical Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry, Molecular Biology and Cell Biology, Northwestern
University, 2153 North Campus Dr., Evanston, IL 60208-3500. Phone:
(847) 491-5433. Fax: (847) 491-2467. E-mail: ralamb{at}nwu.edu.
 |
REFERENCES |
| 1.
|
Bauer, C. M.,
L. H. Pinto,
T. A. Cross, and R. A. Lamb.
1999.
The influenza virus M2 ion channel protein: probing the structure of the transmembrane domain in intact cells by using engineered disulfide cross-linking.
Virology
254:196-209[Medline].
|
| 2.
|
Castrucci, M. R., and Y. Kawaoka.
1995.
Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein.
J. Virol.
69:2725-2728[Abstract].
|
| 3.
|
Chizhmakov, I. V.,
F. M. Geraghty,
D. C. Ogden,
A. Hayhurst,
M. Antoniou, and A. J. Hay.
1996.
Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells.
J. Physiol.
494:329-336[Abstract/Free Full Text].
|
| 4.
|
Ciampor, F.,
P. M. Bayley,
M. V. Nermut,
E. M. Hirst,
R. J. Sugrue, and A. J. Hay.
1992.
Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment.
Virology
188:14-24[Medline].
|
| 5.
|
Duff, K. C., and R. H. Ashley.
1992.
The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers.
Virology
190:485-489[Medline].
|
| 6.
|
Duff, K. C.,
P. J. Gilchrist,
A. M. Saxena, and J. P. Bradshaw.
1994.
Neutron diffraction reveals the site of amantadine blockade in the influenza A M2 ion channel.
Virology
202:287-293[Medline].
|
| 7.
|
Duff, K. C.,
S. M. Kelly,
N. C. Price, and J. P. Bradshaw.
1992.
The secondary structure of influenza A M2 transmembrane domain.
FEBS Lett.
311:256-258[Medline].
|
| 8.
|
Flinta, C.,
B. Persson,
H. Jornvall, and G. von Heijne.
1986.
Sequence determinants of cytosolic N-terminal protein processing.
Eur. J. Biochem.
154:193-196[Medline].
|
| 9.
|
Forrest, L. R.,
W. F. DeGrado,
G. R. Dieckmann, and M. S. Sansom.
1998.
Two models of the influenza A M2 channel domain: verification by comparison.
Fold Design.
3:443-448[Medline].
|
| 10.
|
Fuller, C. M.,
I. I. Ismailov,
B. K. Berdiev,
V. G. Shlyonsky, and D. J. Benos.
1996.
Kinetic interconversion of rat and bovine homologs of the alpha subunit of an amiloride-sensitive Na+ channel by C-terminal truncation of the bovine subunit.
J. Biol. Chem.
271:26602-26608[Abstract/Free Full Text].
|
| 11.
|
Gandhi, C. S.,
K. Shuck,
J. D. Lear,
G. R. Dieckmann,
W. F. DeGrado,
R. A. Lamb, and L. H. Pinto.
1999.
Cu(II) inhibition of the proton translocation machinery of the influenza A virus M2 protein.
J. Biol. Chem.
274:5474-5482[Abstract/Free Full Text].
|
| 12.
|
Giffin, K.,
R. K. Rader,
M. H. Marino, and R. W. Forgey.
1995.
Novel assay for the influenza virus M2 channel activity.
FEBS Lett.
357:269-274[Medline].
|
| 13.
|
Grambas, S., and A. J. Hay.
1992.
Maturation of influenza A virus hemagglutinin estimates of the pH encountered during transport and its regulation by the M2 protein.
Virology
190:11-18[Medline].
|
| 14.
|
Hay, A. J.
1992.
The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein.
Semin. Virol.
3:21-30.
|
| 15.
|
Hay, A. J.,
A. J. Wolstenholme,
J. J. Skehel, and M. H. Smith.
1985.
The molecular basis of the specific anti-influenza action of amantadine.
EMBO J.
4:3021-3024[Medline].
|
| 16.
|
Holsinger, L. J., and R. A. Lamb.
1991.
Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds.
Virology
183:32-43[Medline].
|
| 17.
|
Holsinger, L. J.,
D. Nichani,
L. H. Pinto, and R. A. Lamb.
1994.
Influenza A virus M2 ion channel protein: a structure-function analysis.
J. Virol.
68:1551-1563[Abstract/Free Full Text].
|
| 18.
|
Holsinger, L. J.,
M. A. Shaughnessy,
A. Micko,
L. H. Pinto, and R. A. Lamb.
1995.
Analysis of the posttranslational modifications of the influenza virus M2 protein.
J. Virol.
69:1219-1225[Abstract].
|
| 19.
|
Hopkins, W. F.,
V. Demas, and B. L. Tempel.
1994.
Both N- and C-terminal regions contribute to the assembly and functional expression of homo- and heteromultimeric voltage-gated K+ channels.
J. Neurosci.
14:1385-1393[Abstract].
|
| 20.
|
Hoshi, T.,
W. N. Zagotta, and R. W. Aldrich.
1990.
Biophysical and molecular mechanisms of Shaker potassium channel inactivation.
Science
250:533-538[Abstract/Free Full Text].
|
| 21.
|
Hoshi, T.,
W. N. Zagotta, and R. W. Aldrich.
1991.
Two types of inactivation in Shaker K+ channels: effects of alterations in the carboxy-terminal region.
Neuron
7:547-556[Medline].
|
| 22.
|
Jerng, H. H., and M. Covarrubias.
1997.
K+ channel inactivation mediated by the concerted action of the cytoplasmic N- and C-terminal domains.
Biophys. J.
72:163-174[Medline].
|
| 23.
|
Kovacs, F. A., and T. A. Cross.
1997.
Transmembrane four-helix bundle of influenza A M2 protein channel: structural implications from helix tilt and orientation.
Biophys. J.
73:2511-2517[Medline].
|
| 24.
|
Kukol, A.,
P. D. Adams,
L. M. Rice,
A. T. Brunger, and T. I. Arkin.
1999.
Experimentally based orientational refinement of membrane protein models: a structure for the influenza A M2 H+ channel.
J. Mol. Biol.
286:951-962[Medline].
|
| 25.
|
Lamb, R. A.,
L. J. Holsinger, and L. H. Pinto.
1994.
The influenza A virus M2 ion channel protein and its role in the influenza virus life cycle, p. 303-321.
In
E. Wimmer (ed.), Receptor-mediated virus entry into cells. Cold Spring Harbor Press, Cold Spring Harbor, N.Y
|
| 26.
|
Lamb, R. A.,
C.-J. Lai, and P. W. Choppin.
1981.
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins.
Proc. Natl. Acad. Sci. USA
78:4170-4174[Abstract/Free Full Text].
|
| 27.
|
Lamb, R. A.,
S. L. Zebedee, and C. D. Richardson.
1985.
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.
Cell
40:627-633[Medline].
|
| 28.
|
Liu, S.,
S. Taffet,
L. Stoner,
M. Delmar,
M. L. Vallano, and J. Jalife.
1993.
A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxyl tail length.
Biophys. J.
64:1422-1433[Medline].
|
| 29.
|
Panayotov, P. P., and R. W. Schlesinger.
1992.
Oligomeric organization and strain-specific proteolytic modification of the virion M2 protein of influenza A H1N1 viruses.
Virology
186:352-355[Medline].
|
| 30.
|
Park, E. K.,
M. R. Castrucci,
A. Portner, and Y. Kawaoka.
1998.
The M2 ectodomain is important for its incorporation into influenza A virions.
J. Virol.
72:2449-2455[Abstract/Free Full Text].
|
| 31.
|
Pinto, L. H.,
G. R. Dieckmann,
C. S. Gandhi,
C. G. Papworth,
J. Braman,
M. A. Shaughnessy,
J. D. Lear,
R. A. Lamb, and W. F. DeGrado.
1997.
A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity.
Proc. Natl. Acad. Sci. USA
94:11301-11306[Abstract/Free Full Text].
|
| 32.
|
Pinto, L. H.,
L. J. Holsinger, and R. A. Lamb.
1992.
Influenza virus M2 protein has ion channel activity.
Cell
69:517-528[Medline].
|
| 33.
|
Sakaguchi, T.,
G. P. Leser, and R. A. Lamb.
1996.
The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus.
J. Cell Biol.
133:733-747[Abstract/Free Full Text].
|
| 34.
|
Sakaguchi, T.,
Q. Tu,
L. H. Pinto, and R. A. Lamb.
1997.
The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer.
Proc. Natl. Acad. Sci. USA
94:5000-5004[Abstract/Free Full Text].
|
| 35.
|
Sansom, M. S. P.,
I. D. Kerr,
G. R. Smith, and H. S. Son.
1997.
The influenza A virus M2 channel: a molecular modeling and simulation study.
Virology
233:162-173.
|
| 36.
|
Schroeder, C.,
C. M. Ford,
S. A. Wharton, and A. J. Hay.
1994.
Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: evidence for proton transfer activity.
J. Gen. Virol.
75:3477-3484[Abstract/Free Full Text].
|
| 37.
|
Shimbo, K.,
D. L. Brassard,
R. A. Lamb, and L. H. Pinto.
1996.
Ion selectivity and activation of the M2 ion channel of influenza virus.
Biophys. J.
70:1335-1346[Medline].
|
| 38.
|
Shimbo, K.,
D. L. Brassard,
R. A. Lamb, and L. H. Pinto.
1995.
Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes.
Biophys. J.
69:1819-1829[Medline].
|
| 39.
|
Sugrue, R. J.,
R. B. Belshe, and A. J. Hay.
1990.
Palmitoylation of the influenza A virus M2 protein.
Virology
179:51-56[Medline].
|
| 40.
|
Sugrue, R. J., and A. J. Hay.
1991.
Structural characteristics of the M2 protein of the influenza A viruses: evidence that it forms a tetrameric channel.
Virology
180:617-624[Medline].
|
| 41.
|
Tosteson, M. T.,
L. H. Pinto,
L. J. Holsinger, and R. A. Lamb.
1994.
Reconstitution of the influenza virus M2 ion channel in lipid bilayers.
J. Membr. Biol.
142:117-126[Medline].
|
| 42.
|
Veit, M.,
H.-D. Klenk,
A. Kendal, and R. Rott.
1991.
The M2 protein of influenza A virus is acylated.
Virology
184:227-234[Medline].
|
| 43.
|
Wang, C.,
R. A. Lamb, and L. H. Pinto.
1995.
Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue.
Biophys. J.
69:1363-1371[Medline].
|
| 44.
|
Wang, C.,
R. A. Lamb, and L. H. Pinto.
1994.
Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells.
Virology
205:133-140[Medline].
|
| 45.
|
Wang, C.,
K. Takeuchi,
L. H. Pinto, and R. A. Lamb.
1993.
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
J. Virol.
67:5585-5594[Abstract/Free Full Text].
|
| 46.
|
Zebedee, S. L., and R. A. Lamb.
1989.
Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein.
Proc. Natl. Acad. Sci. USA
86:1061-1065[Abstract/Free Full Text].
|
| 47.
|
Zebedee, S. L., and R. A. Lamb.
1988.
Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.
J. Virol.
62:2762-2772[Abstract/Free Full Text].
|
| 48.
|
Zebedee, S. L.,
C. D. Richardson, and R. A. Lamb.
1985.
Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA.
J. Virol.
56:502-511[Abstract/Free Full Text].
|
| 49.
|
Zhong, Q.,
T. Husslein,
P. B. Moore,
D. M. Newns,
P. Pattnaik, and M. L. Klein.
1998.
The M2 channel of influenza A virus: a molecular dynamics study.
FEBS Lett.
434:265-271[Medline].
|
Journal of Virology, December 1999, p. 9695-9701, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chen, B. J., Leser, G. P., Jackson, D., Lamb, R. A.
(2008). The Influenza Virus M2 Protein Cytoplasmic Tail Interacts with the M1 Protein and Influences Virus Assembly at the Site of Virus Budding. J. Virol.
82: 10059-10070
[Abstract]
[Full Text]
-
Balannik, V., Lamb, R. A., Pinto, L. H.
(2008). The Oligomeric State of the Active BM2 Ion Channel Protein of Influenza B Virus. J. Biol. Chem.
283: 4895-4904
[Abstract]
[Full Text]
-
Imai, M., Kawasaki, K., Odagiri, T.
(2008). Cytoplasmic Domain of Influenza B Virus BM2 Protein Plays Critical Roles in Production of Infectious Virus. J. Virol.
82: 728-739
[Abstract]
[Full Text]
-
Wu, W.-H., Pekosz, A.
(2008). Extending the Cytoplasmic Tail of the Influenza A Virus M2 Protein Leads to Reduced Virus Replication In Vivo but Not In Vitro. J. Virol.
82: 1059-1063
[Abstract]
[Full Text]
-
McCown, M. F., Pekosz, A.
(2006). Distinct domains of the influenza a virus m2 protein cytoplasmic tail mediate binding to the m1 protein and facilitate infectious virus production.. J. Virol.
80: 8178-8189
[Abstract]
[Full Text]
-
Iwatsuki-Horimoto, K., Horimoto, T., Noda, T., Kiso, M., Maeda, J., Watanabe, S., Muramoto, Y., Fujii, K., Kawaoka, Y.
(2006). The cytoplasmic tail of the influenza a virus m2 protein plays a role in viral assembly.. J. Virol.
80: 5233-5240
[Abstract]
[Full Text]
-
Pinto, L. H., Lamb, R. A.
(2006). The M2 Proton Channels of Influenza A and B Viruses. J. Biol. Chem.
281: 8997-9000
[Full Text]
-
McCown, M. F., Pekosz, A.
(2005). The Influenza A Virus M2 Cytoplasmic Tail Is Required for Infectious Virus Production and Efficient Genome Packaging. J. Virol.
79: 3595-3605
[Abstract]
[Full Text]
-
Decoursey, T. E.
(2003). Voltage-Gated Proton Channels and Other Proton Transfer Pathways. Physiol. Rev.
83: 475-579
[Abstract]
[Full Text]
-
Tang, Y., Zaitseva, F., Lamb, R. A., Pinto, L. H.
(2002). The Gate of the Influenza Virus M2 Proton Channel Is Formed by a Single Tryptophan Residue. J. Biol. Chem.
277: 39880-39886
[Abstract]
[Full Text]
-
Takeda, M., Pekosz, A., Shuck, K., Pinto, L. H., Lamb, R. A.
(2002). Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture. J. Virol.
76: 1391-1399
[Abstract]
[Full Text]
-
Watanabe, T., Watanabe, S., Ito, H., Kida, H., Kawaoka, Y.
(2001). Influenza A Virus Can Undergo Multiple Cycles of Replication without M2 Ion Channel Activity. J. Virol.
75: 5656-5662
[Abstract]
[Full Text]
-
Shuck, K., Lamb, R. A., Pinto, L. H.
(2000). Analysis of the Pore Structure of the Influenza A Virus M2 Ion Channel by the Substituted-Cysteine Accessibility Method. J. Virol.
74: 7755-7761
[Abstract]
[Full Text]